JDP is reluctant to speculate publicly.
But speculation abhors a vacuum.
My SPECULATION repeat SPECULATION is:
The UON has already started a quick and cheap in-vitro check on human heart cells (HCMs) to see if bisantrene protects the HCMs in vitro against the direct cardiotoxity of the 15 drugs identified in the 15 February 2024 published study which JDP found and kindly announced in a PS HC post which RAC is studiously ignoring. (Note that HC software doesn't cater for identifying PS posts - they think that only companies make PS announcements).
Bisantrene has already demonstrated CPACS with two unrelated classes of drugs. For the unannounced preclinical currently underway, only the CP aspect is relevant.
When the results of this follow-on preclinical study are published, RAC will ignore them for two reasons:
* IP considerations
* because, if they were acknowledged by RAC, bisantrene's TAM would become even harder to believe than it already is and the Triangle report would be downramping.
However a RAC shareholder will find the journal article and post a PS link in this thread.
- Forums
- ASX - By Stock
- RAC
- Cardioprotection thread
Cardioprotection thread, page-286
-
-
- There are more pages in this discussion • 620 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.69 |
Change
0.010(0.60%) |
Mkt cap ! $287.1M |
Open | High | Low | Value | Volume |
$1.69 | $1.70 | $1.65 | $89.01K | 53.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2342 | $1.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.70 | 5 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2342 | 1.685 |
1 | 3664 | 1.680 |
1 | 5077 | 1.660 |
1 | 1265 | 1.650 |
1 | 612 | 1.635 |
Price($) | Vol. | No. |
---|---|---|
1.695 | 5 | 1 |
1.700 | 11000 | 1 |
1.730 | 2399 | 1 |
1.750 | 952 | 2 |
1.775 | 1328 | 1 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online